PLVAP and hepatocellular carcinoma: On the other hand, PLVAP was identified as a gene expressed explicitly in HCC vascular endothelial cells (46), and has been investigated as a therapeutic target in HCC (46), perhaps based on its ability to alter the immunosuppressive microenvironment (47).